Name
Asimov
What We Do
Asimov is developing a synthetic biology platform – from cells to software – to enable better design and manufacture of next-generation therapeutics. Asimov’s CHO Edge System for biologic production minimizes the risk of cell line development by enabling exploration of vector design space, routinely achieving titers of 8–12 g/L across modalities.
Asimov is applying the same approach to improve cell & gene therapies – by developing stable lentiviral cell lines and a best-in-class AAV expression
Asimov is applying the same approach to improve cell & gene therapies – by developing stable lentiviral cell lines and a best-in-class AAV expression
Founded
2017
Website
Categories (3)
Gene Therapy, CAR T/Oncolytics, Cell Line Development
Address
201 Brookline Ave, Suite 1201
02215
02215